1. Home
  2. COCO vs LQDA Comparison

COCO vs LQDA Comparison

Compare COCO & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Vita Coco Company Inc.

COCO

The Vita Coco Company Inc.

HOLD

Current Price

$47.25

Market Cap

3.0B

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$37.80

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COCO
LQDA
Founded
2004
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.1B
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
COCO
LQDA
Price
$47.25
$37.80
Analyst Decision
Buy
Strong Buy
Analyst Count
9
11
Target Price
$57.75
$41.00
AVG Volume (30 Days)
1.6M
1.1M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
26.60
51.81
EPS
1.19
N/A
Revenue
N/A
$158,320,000.00
Revenue This Year
$16.12
$278.87
Revenue Next Year
$11.40
$57.13
P/E Ratio
$40.54
N/A
Revenue Growth
N/A
1031.18
52 Week Low
$29.74
$11.85
52 Week High
$61.39
$46.67

Technical Indicators

Market Signals
Indicator
COCO
LQDA
Relative Strength Index (RSI) 39.51 49.78
Support Level $45.02 $31.75
Resistance Level $48.67 $39.19
Average True Range (ATR) 2.54 2.12
MACD -0.01 0.09
Stochastic Oscillator 34.18 37.52

Price Performance

Historical Comparison
COCO
LQDA

About COCO The Vita Coco Company Inc.

The Vita Coco Co Inc is a plant-based functional hydration platform. Its products include Vita Coco Coconut Water, Private Label including coconut water and oil, and Other including Runa, Ever & Ever, and PWR LIFT product offerings, Vita Coco product extensions beyond coconut water, such as Vita Coco Sparkling, coconut milk products, and others. The company has two segments: The Americas segment which comprises of operations in the U.S. and Canada; and The International segment that comprises of operations in Europe, the Middle East, Africa and the Asia Pacific regions. The Americas segment derives maximum revenue. Geographical presence of the company is in United States, United Kingdom and All other countries.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: